POLISCOPE
Back to feed
NewsFOX 13 Tampa BayAugust 26, 2026Hillsborough

Vitruvias Therapeutics recalls specific lot of 30 mg thyroid tablets due to superpotency risk

Vitruvias Therapeutics has issued a voluntary recall for one lot of its 30 mg Thyroid Tablets, USP, because the medication may be 'superpotent,' potentially causing hyperthyroidism. The recall affects products distributed between January 31, 2025, and September 30, 2025, with an expiration date of September 30, 2026.

public healthproduct recallpharmaceuticalsFDA
Read the full story at FOX 13 Tampa Bay

Why It Matters

Patients taking this specific medication may face health risks from excessive dosage, including weight loss, muscle weakness, and chest pain, and should consult their doctor before stopping use.

Key Facts

  • Vitruvias Therapeutics is recalling Lot 504950 of its Thyroid Tablets, USP 30 mg.
  • The recall was initiated due to the potential for the tablets to be 'superpotent,' meaning they contain a higher concentration of the active ingredient than intended.
  • Superpotent thyroid medication can cause hyperthyroidism, with symptoms including weight loss, muscle weakness, and chest pain.
  • Elderly individuals, infants, and pregnant women are at a higher risk for complications from hyperthyroidism.
  • The affected tablets were distributed between January 31, 2025, and September 30, 2025.
  • The recalled lot has an expiration date of September 30, 2026.
  • No adverse effects have been reported to the company to date.
  • Patients are advised not to stop taking the medication without first consulting a healthcare provider for a replacement.
  • Wholesalers have been instructed to stop distributing the affected lot and arrange for its destruction.
  • Adverse reactions can be reported to the FDA’s MedWatch program.

Who's Mentioned

organizationFood and Drug Administration“The federal agency overseeing the drug recall and safety reporting.”organizationVitruvias Therapeutics, Inc.“The drug manufacturer issuing the recall.”other504950“The specific lot number of the recalled thyroid tablets.”other30“The dosage strength of the recalled tablets in milligrams.”